Two different Jkt cell lines were used in this study:
bcl-x L /Jkt or
Neo/Jkt cells.
Both cell lines were generously provided by Craig B. Thompson and
Mathew G. Vander Heiden (Department of Medicine, University of
Chicago, Chicago, IL). The
bcl-x L /Jkt cell
line was generated by the stable transfection of Jkt cells with both
the neomycin-resistant gene and the
bcl-x L antiapoptosis human gene (
bcl-x L /Jkt). The
Neo/Jkt cell line, which served as control, was only
transfected with the neomycin-resistant gene (
Neo/Jkt). Both
Jkt cell lines are type II cells, as defined by their ability to
prevent Fas-mediated apoptosis by overexpression of the antiapoptotic
bcl-2 family member
bcl-x L .
15 16 The Jkt cells
were cultured in standard culture medium containing RPMI 1640
(BioWhittaker) supplemented with 20 mM glutamine (BioWhittaker), 10%
heat inactivated fetal calf serum (GIBCO, Life Technologies, Grand
Island, NY), 100 IU/ml penicillin, 100 μg/ml streptomycin
(BioWhittaker), and 20 mM HEPES (BioWhittaker). The cultures were
incubated at 37°C in a humidified mixture of 95% air and 5%
CO
2. For selection purposes 0.5 mg/ml of G418
(GIBCO, Life Technologies) was added to the cultures.